Your browser doesn't support javascript.
loading
Prevalence of CYP2C19*2 carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setup.
Al-Rubaish, Abdullah M; Al-Muhanna, Fahad A; Alshehri, Abdullah M; Alsulaiman, Abdulla A; Alabdulali, Majed M; Alkhamis, Fahad; Alamri, Abdulallh S; Alali, Rudaynah A; Akhtar, Mohammed S; Cyrus, Cyril; Claassens, Daniel M F; Asselbergs, Folkert W; Al-Ali, Amein K.
Afiliación
  • Al-Rubaish AM; Department of Internal Medicine, King Fahd Hospital of the University, Al-Khobar and College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Al-Muhanna FA; Department of Internal Medicine, King Fahd Hospital of the University, Al-Khobar and College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Alshehri AM; Department of Internal Medicine, King Fahd Hospital of the University, Al-Khobar and College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Alsulaiman AA; Department of Neurology, King Fahd Hospital of the University, Al-Khobar, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Alabdulali MM; Department of Neurology, King Fahd Hospital of the University, Al-Khobar, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Alkhamis F; Department of Neurology, King Fahd Hospital of the University, Al-Khobar, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Alamri AS; Department of Neurology, King Fahd Hospital of the University, Al-Khobar, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Alali RA; Department of Internal Medicine, King Fahd Hospital of the University, Al-Khobar and College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Akhtar MS; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Cyrus C; Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
  • Claassens DMF; Department of Cardiology, Saint Antonius Hospital, Nieuwegein, The Netherlands.
  • Asselbergs FW; Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Al-Ali AK; Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
Drug Metab Pers Ther ; 2021 Jul 08.
Article en En | MEDLINE | ID: mdl-34237806
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Drug Metab Pers Ther Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Drug Metab Pers Ther Año: 2021 Tipo del documento: Article País de afiliación: Arabia Saudita